Longboard Pharmaceuticals Inc (LBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LBPH | AMGN | VRTX | BMY | GILD |
| Company | Longboard Pharmaceuticals Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 59.76 | 291.50 | 478.56 | 58.16 | 91.71 |
| High | 59.83 | 291.50 | 479.94 | 58.36 | 91.99 |
| Low | 59.47 | 279.62 | 458.10 | 56.21 | 89.03 |
| Last | 59.71 | 280.81 | 461.97 | 56.46 | 89.43 |
| Change | -0.03 | -15.12 | -21.99 | -2.04 | -2.68 |
| % Change | -0.05% | -5.11% | -4.54% | -3.49% | -2.91% |
| Volume | 803,413 | 2,782,392 | 1,304,151 | 10,596,251 | 4,519,159 |
| 20-Day Average Volume | 1,032,182 | 2,378,900 | 1,129,312 | 10,987,428 | 6,965,354 |
| Previous Close | 59.74 | 295.93 | 483.96 | 58.50 | 92.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 59.65 | 313.77 | 482.85 | 54.92 | 90.72 |
| 20-Day Raw Stochastic | 79.20% | 0.30% | 2.50% | 49.73% | 26.80% |
| 20-Day Relative Strength | 75.95% | 27.36% | 43.07% | 57.15% | 52.18% |
| Weighted Alpha | +178.14 | -2.93 | +22.26 | +19.13 | +25.19 |
| Today's Opinion | 100% Buy | 40% Sell | 16% Buy | 100% Buy | 80% Buy |
| Previous Opinion | 100% Buy | 40% Sell | 72% Buy | 100% Buy | 96% Buy |
| Last Month's Opinion | 100% Buy | 24% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.16% since 11/08/24 | -13.86% since 11/08/24 | -11.05% since 11/08/24 | +4.21% since 11/08/24 | -7.66% since 11/08/24 |
| Low | 59.47 on 11/15/24 | 280.05 on 11/15/24 | 458.10 on 11/15/24 | 56.37 on 11/15/24 | 89.08 on 11/15/24 |
| High | 59.88 on 11/11/24 | 327.58 on 11/11/24 | 518.35 on 11/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 1-Month | |||||
| %Chg | +1.07% since 10/15/24 | -13.81% since 10/15/24 | -5.09% since 10/15/24 | +6.94% since 10/15/24 | +3.90% since 10/15/24 |
| Low | 58.82 on 11/04/24 | 280.05 on 11/15/24 | 458.10 on 11/15/24 | 51.81 on 10/28/24 | 85.60 on 10/22/24 |
| High | 59.95 on 11/01/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +71.01% since 08/15/24 | -13.89% since 08/15/24 | -2.62% since 08/15/24 | +14.88% since 08/15/24 | +19.94% since 08/15/24 |
| Low | 27.35 on 09/17/24 | 280.05 on 11/15/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 72.89 on 08/16/24 |
| High | 59.95 on 11/01/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +182.47% since 05/15/24 | -12.18% since 05/15/24 | +5.06% since 05/15/24 | +26.64% since 05/15/24 | +33.06% since 05/15/24 |
| Low | 15.64 on 06/10/24 | 280.05 on 11/15/24 | 432.22 on 05/16/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 59.95 on 11/01/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,323,886 | 159,072,144 | 124,633,728 | 118,648,352 | 114,793,560 |
| Shares Outstanding, K | 38,900 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -54,420,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -24,540,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 1.07 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.63 on 11/07/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/07/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.68 | 0.00 | 49.92 | 20.91 |